𝔖 Bobbio Scriptorium

✦ LIBER ✦

Switching from donepezil to galantamine: a double-blind study of two wash-out periods

✍ Scribed by David G. Wilkinson; Ian Howe

Book ID: 102226861
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 48 KB
Volume: 20
Category: Article
ISSN: 0885-6230
DOI: 10.1002/gps.1301

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contribution of a Heating Element to Top

Contribution of a Heating Element to Topical Anesthesia Patch Efficacy Prior to Vascular Access: Results From Two Randomized, Double-Blind Studies

✍ Salman Masud; Richard D. Wasnich; Jon L. Ruckle; William T. Garland; Stephen W. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 411 KB

Early switching from morphine to methado

Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, randomized, double-blind, placebo-controlled study

✍ Daniel I. G. Cubero; Auro del Giglio 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 167 KB

Efficacy and tolerability of a new formu

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Efficacy and tolerability of nebivolol m

Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: A retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension

✍ F. Wilford Germino 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

346 EFFICACY AND SAFETY OF TEVERELIX LA,

346 EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 60 MG AT 48 HOURS INTERVAL ADMINISTERED S.C. TO TREATMENT NAÏVE PATIENTS SUFFERING FROM BPH

✍ C. Maclean; F. Larsen; J. Drewe; A.V. Dzmitryieu; A. Gres; A. Strockyi; V. Dovge 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 332 KB

EFFICACY AND SAFETY OF TEVERELIX LA, A N

EFFICACY AND SAFETY OF TEVERELIX LA, A NEW GNRH ANTAGONIST IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA (BPH). RESULTS FROM A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE, MULTINATIONAL STUDY INVESTIGATING TWO SINGLE INJECTIONS OF 30 MG OR 60 MG (SEPARATED BY AT LEAST 12 WEEKS) ADMINISTERED SC TO TREATMENT NAIVE PATIENTS SUFFERING FROM BPH

✍ C.M. Maclean; L. Skillern; F. Larsen; A. Gres; A. Strotski; A.V. Dmitrijev; V.K. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB